Our aim is to achieve the highest possible scientific and ethical standards, by putting the interests of patients first and to work with integrity and fairness with all our partners.
Through our historical links with doctors in the NHS, the unit conducts studies in both primary and secondary care, many of which are risk management studies which are part of Risk Management Plans (RMPs) in the EU.
Our activities are principally concerned with pharmacovigilance, that is, the detection of side-effects associated with the use of marketed drugs. The DSRU undertakes all forms of research studies and evaluations of the safety of medicines and provides education and training in pharmacovigilance and related subjects.
The DSRU is an independent unit providing scientific excellence demonstrated through conducting studies which are used to support public health decisions and production of publications in international peer reviewed journals since 1980.
The DSRU makes significant, valuable contributions in the area of post marketing surveillance of pharmaceutical products. We have achieved both recognition and endorsement by the regulatory authorities, healthcare professionals and pharmaceutical industry worldwide.
The DSRU have been providing pharmacovigilance training in the UK since 2000, to fulfil the requirements of professionals from around the world in pharmacovigilance. We are one of the leading providers of pharmacovigilance training in Europe. Our portfolio of short courses, conferences and postgraduate programmes in pharmacovigilance are supported by a broad range International companies. Our practical expertise in pharmacovigilance makes us Experts in Pharmacovigilance Education.